Abstract
The incidence of autoimmune diseases is increasing in Western countries, possibly due to the improved sanitary conditions and reduced exposure to infections in childhood (the hygiene hypothesis). There is an ongoing debate whether infection prevents or precipitates autoimmune diseases. Various helminths species used in several animal models were shown to limit inflammatory activity in a variety of diseases including inflammatory bowel disease, multiple sclerosis, type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. At present the scientific data is based mostly on experimental animal models; however, there is an increasing body of evidence in a number of clinical trials being conducted. Herein we review several clinical trials evaluating the anti-inflammatory effects of helminths and assessing their association with different autoimmune diseases, including inflammatory bowel disease, multiple sclerosis, and autoimmune liver diseases. We also describe the common pathways by which helminths induce immune modulation and the key changes observed in the host immune system following exposure to helminths. These common pathways include the inhibition of IFN-γ and IL-17 production, promotion of IL-4, IL-10 and TGF-β release, induction of CD4(+) T cell FoxP3+ expression, and generation of regulatory macrophages, dendritic cells, and B cells. Helminths products are becoming significant candidates for anti-inflammatory agents in this context. However, further research is needed for synthetic analogues of helminths' potent products that mimic the parasite-mediated immunomodulation effect.
Similar content being viewed by others
References
Strachan DP (1989) Hay fever, hygiene, and household size. BMJ 299:1259–1260
Motomura Y, Wang H, Deng Y, El-Sharkawy RT, Verdu EF, Khan WI (2009) Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Clin Exp Immunol 155:88–95
Reardon C, Sanchez A, Hogaboam CM, McKay DM (2001) Tapeworm infection reduces epithelial ion transport abnormalities in murine dextran sulfate sodium-induced colitis. Infect Immun 69:4417–4423
Marshall FA, Watson KA, Garside P, Harnett MM, Harnett W (2008) Effect of activated antigen-specific B cells on ES-62-mediated modulation of effector function of heterologous antigen-specific T cells in vivo. Immunology 123:411–425
Harnett MM, Kean DE, Boitelle A et al (2008) The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis. Ann Rheum Dis 67:518–523
Sagi L, Baum S, Agmon-Levin N et al (2011) Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev 10:527–535
Saunders KA, Raine T, Cooke A, Lawrence CE (2007) Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 75:397–407
Cooke A, Tonks P, Jones FM et al (1999) Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 21:169–176
Cooke A (2009) Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes? Immunology 126:12–17
Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV (2005) Trichuris suis therapy in Crohn's disease. Gut 54:87–90
Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128:825–832
Summers RW, Elliott DE, Weinstock JV (2005) Is there a role for helminths in the therapy of inflammatory bowel disease? Nat Clin Pract Gastroenterol Hepatol 2:62–63
Kahana E (2000) Epidemiologic studies of multiple sclerosis: a review. Biomed Pharmacother 54:100–102
Fleming JO, Cook TD (2006) Multiple sclerosis and the hygiene hypothesis. Neurology 67:2085–2086
Butterworth AE, Curry AJ, Dunne DW et al (1994) Immunity and morbidity in human schistosomiasis mansoni. Trop Geogr Med 46:197–208
Sewell D, Qing Z, Reinke E et al (2003) Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 15:59–69
La Flamme AC, Ruddenklau K, Backstrom BT (2003) Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 71:4996–5004
Zheng X, Hu X, Zhou G et al (2008) Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. J Neuroimmunol 194:107–114
Gruden-Movsesijan A, Ilic N, Mostarica-Stojkovic M, Stosic-Grujicic S, Milic M, Sofronic-Milosavljevic L (2008) Trichinella spiralis: modulation of experimental autoimmune encephalomyelitis in DA rats. Exp Parasitol 118:641–647
Walsh KP, Brady MT, Finlay CM, Boon L, Mills KH (2009) Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 183:1577–1586
Elliott DE, Weinstock JV (2012) Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci 1247:83–96
Zaccone P, Fehervari Z, Jones FM et al (2003) Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 33:1439–1449
Elliott DE, Metwali A, Leung J et al (2008) Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J Immunol 181:2414–2419
Elliott DE, Urban JJ, Argo CK, Weinstock JV (2000) Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J 14:1848–1855
Elliott DE, Li J, Blum A et al (2003) Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 284:G385–G391
Kuijk LM, van Die I (2010) Worms to the rescue: can worm glycans protect from autoimmune diseases? IUBMB Life 62:303–312
Moreels TG, Nieuwendijk RJ, De Man JG et al (2004) Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut 53:99–107
Ruyssers NE, De Winter BY, De Man JG et al (2009) Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis 15:491–500
Ruyssers NE, De Winter BY, De Man JG et al (2010) Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol 16:703–712
Hunter MM, Wang A, McKay DM (2007) Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology 132:1320–1330
Smith P, Mangan NE, Walsh CM et al (2007) Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 178:4557–4566
Hsu SJ, Tseng PH, Chen PJ (2005) Trichuris suis therapy for ulcerative colitis: nonresponsive patients may need anti-helminth therapy. Gastroenterology 129:768–769, author reply 9
Croese J, O'Neil J, Masson J et al (2006) A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut 55:136–137
Mortimer K, Brown A, Feary J et al (2006) Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. AmJTrop Med Hyg 75:914–920
Correale J, Farez M (2007) Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 61:97–108
Correale J, Farez MF (2011) The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 233:6–11
Correale J, Farez M, Razzitte G (2008) Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 64:187–199
Aoyama H, Hirata T, Sakugawa H et al (2007) An inverse relationship between autoimmune liver diseases and Strongyloides stercoralis infection. AmJTrop Med Hyg 76:972–976
Gause WC, Urban JF Jr, Stadecker MJ (2003) The immune response to parasitic helminths: insights from murine models. Trends Immunol 24:269–277
Lammas DA, Casanova JL, Kumararatne DS (2000) Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway. Clin Exp Immunol 121:417–425
Krug N, Madden J, Redington AE et al (1996) T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 14:319–326
Klunker S, Trautmann A, Akdis M et al (2003) A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J Immunol 171:1078–1084
Park H, Li Z, Yang XO et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133–1141
Osada Y, Kanazawa T (2010) Parasitic helminths: new weapons against immunological disorders. J Biomed Biotechnol 2010:1–9
Aranami T, Yamamura T (2008) Th17 Cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int 57:115–120
Tozawa K, Hanai H, Sugimoto K et al (2003) Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice. J Gastroenterol Hepatol 18:578–587
Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK (2006) Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 12:382–388
Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C (2009) Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 39:216–224
Harnett MM, Melendez AJ, Harnett W (2010) The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. Clin Exp Immunol 159:256–267
Wu Z, Nagano I, Asano K, Takahashi Y (2010) Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response. Parasitol Res 107:1173–1188
Osada Y, Shimizu S, Kumagai T, Yamada S, Kanazawa T (2009) Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int J Parasitol 39:457–464
Mo HM, Liu WQ, Lei JH, Cheng YL, Wang CZ, Li YL (2007) Schistosoma japonicum eggs modulate the activity of CD4+ CD25+ Tregs and prevent development of colitis in mice. Exp Parasitol 116:385–389
Zaccone P, Burton OT, Gibbs S et al (2010) Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J Biomed Biotechnol 2010:795210
Duez C, Gosset P, Tonnel AB (2006) Dendritic cells and toll-like receptors in allergy and asthma. Eur J Dermatol 16:12–16
Kane CM, Cervi L, Sun J et al (2004) Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol 173:7454–7461
Rocha FA, Leite AK, Pompeu MM et al (2008) Protective effect of an extract from Ascaris suum in experimental arthritis models. Infect Immun 76:2736–2745
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ben-Ami Shor, D., Harel, M., Eliakim, R. et al. The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity. Clinic Rev Allerg Immunol 45, 211–216 (2013). https://doi.org/10.1007/s12016-012-8352-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-012-8352-9